Previous 10 | Next 10 |
Oasmia Pharmaceutical AB (NASDAQ: OASM ) +22% . More news on: Oasmia Pharmaceutical AB (publ), Sangamo Therapeutics, Inc., Aytu BioScience, Inc., Stocks on the move, Read more ...
Aytu BioScience's (NASDAQ: AYTU ) study titled, Efficacy of Nasal Testosterone Gel (Natesto) Stratified by Baseline Endogenous Testosterone Levels, achieves similar symptom improvement , regardless of the degree of patients’ testosterone deficiency, while maintaining function of...
First Natesto Study to Demonstrate Efficacy in Severely Hypogonadal Patients ENGLEWOOD, CO / ACCESSWIRE / July 8, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced t...
ENGLEWOOD, CO / ACCESSWIRE / July 1, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced that it has been added to the Russell Microcap® Index effective after the U.S....
ENGLEWOOD, CO / ACCESSWIRE / July 1, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced that it has been added to the Russell Microcap® Index effective after the U.S....
First Clinical Data Demonstrating Predictive Power of Seminal Oxidation-Reduction Potential (ORP) as a Predictor of Fertilization When Used Prior to IVF ENGLEWOOD, CO / ACCESSWIRE / June 25, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on comm...
ENGLEWOOD, CO / ACCESSWIRE / June 24, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced that the MiOXSYS ® male infertility test will be featured today in a Product...
11 Abstracts Featuring MiOXSYS have been Selected for Presentation at the 35th Annual Meeting of the European Society of Human Reproduction and Embryology ENGLEWOOD, CO / ACCESSWIRE / June 18, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on com...
ENGLEWOOD, CO / ACCESSWIRE / June 12, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, today announced that Natesto® has been featured on KPRC-TV, an NBC-affiliated televisio...
ENGLEWOOD, CO / ACCESSWIRE / June 11, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, is set to join the Russell Microcap ® Index at the conclusion of the 2019 Russell inde...
News, Short Squeeze, Breakout and More Instantly...
Company receives proceeds of $3.5 million through exercise of warrants, a portion of which was used to pay down debt Interest rate on new $13.0 million term loan reduced by approximately 350 basis points today, potentially saving the Company $1.3 million over the life of the term loan T...
Phoenix, Arizona and New York, New York--(Newsfile Corp. - May 29, 2024) - Lytham Partners, a leading investor relations and corporate access firm, today announced the schedule for its Spring 2024 Investor Conference taking place virtually on May 30, 2024. More than 40 companies will be available...
DENVER, CO / ACCESSWIRE / May 23, 2024 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that Josh Disbrow, CEO, will participate in a webcasted fireside chat and host one-on-one meetings with inv...